Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 43% ± 26% | |
adipocyte | 6 studies | 26% ± 4% | |
GABAergic neuron | 6 studies | 41% ± 21% | |
endothelial cell | 4 studies | 25% ± 4% | |
epithelial cell | 4 studies | 19% ± 4% | |
astrocyte | 4 studies | 36% ± 18% | |
oligodendrocyte precursor cell | 4 studies | 21% ± 1% | |
oligodendrocyte | 4 studies | 28% ± 14% | |
microglial cell | 3 studies | 18% ± 1% | |
ciliated cell | 3 studies | 42% ± 19% | |
interneuron | 3 studies | 53% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 37% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 446.60 | 653 / 653 | 98% | 9.40 | 595 / 605 |
ovary | 100% | 396.83 | 180 / 180 | 98% | 8.12 | 422 / 430 |
kidney | 100% | 613.36 | 89 / 89 | 98% | 13.83 | 881 / 901 |
pancreas | 100% | 248.83 | 328 / 328 | 97% | 5.72 | 172 / 178 |
adrenal gland | 100% | 983.38 | 258 / 258 | 96% | 10.48 | 220 / 230 |
prostate | 100% | 385.92 | 245 / 245 | 91% | 9.73 | 455 / 502 |
uterus | 100% | 448.42 | 170 / 170 | 88% | 5.21 | 402 / 459 |
breast | 100% | 378.26 | 458 / 459 | 87% | 5.38 | 977 / 1118 |
liver | 100% | 283.78 | 226 / 226 | 86% | 5.59 | 350 / 406 |
bladder | 100% | 309.24 | 21 / 21 | 78% | 4.26 | 391 / 504 |
lung | 98% | 227.42 | 565 / 578 | 79% | 4.55 | 908 / 1155 |
skin | 100% | 335.15 | 1805 / 1809 | 75% | 4.92 | 353 / 472 |
intestine | 100% | 305.44 | 964 / 966 | 64% | 3.66 | 338 / 527 |
esophagus | 100% | 270.65 | 1440 / 1445 | 50% | 2.37 | 91 / 183 |
stomach | 99% | 371.99 | 355 / 359 | 48% | 2.79 | 138 / 286 |
brain | 98% | 221.15 | 2597 / 2642 | 47% | 1.51 | 332 / 705 |
adipose | 100% | 419.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 248.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.21 | 1 / 1 |
muscle | 100% | 353.55 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 309.93 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 440.34 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 4.96 | 74 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 4.19 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 3.91 | 25 / 29 |
peripheral blood | 48% | 109.76 | 450 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071871 | Biological process | response to epinephrine |
GO_1902074 | Biological process | response to salt |
GO_0010459 | Biological process | negative regulation of heart rate |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0002931 | Biological process | response to ischemia |
GO_0071869 | Biological process | response to catecholamine |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0051379 | Molecular function | epinephrine binding |
GO_0016651 | Molecular function | oxidoreductase activity, acting on NAD(P)H |
GO_0005515 | Molecular function | protein binding |
GO_0097621 | Molecular function | monoamine oxidase activity |
GO_0070404 | Molecular function | NADH binding |
Gene name | RNLS |
Protein name | Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) |
Synonyms | C10orf59 |
Description | FUNCTION: Catalyzes the oxidation of the less abundant 1,2-dihydro-beta-NAD(P) and 1,6-dihydro-beta-NAD(P) to form beta-NAD(P)(+). The enzyme hormone is secreted by the kidney, and circulates in blood and modulates cardiac function and systemic blood pressure. Lowers blood pressure in vivo by decreasing cardiac contractility and heart rate and preventing a compensatory increase in peripheral vascular tone, suggesting a causal link to the increased plasma catecholamine and heightened cardiovascular risk. High concentrations of catecholamines activate plasma renalase and promotes its secretion and synthesis. . |
Accessions | ENST00000371947.7 [Q5VYX0-2] ENST00000331772.9 [Q5VYX0-1] Q5VYX0 |